Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LioCyx-M in Chronic Hepatitis B
NCT06885710Phase 1Recruiting
- Sponsor
- Changhai Hospital
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Gene Editing, Bone Marrow HSCs, Gene Silencing
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of liocyx-m in Chronic Hepatitis B (CHB), sponsored by Changhai Hospital. Primary endpoint: Assessments of adverse events. Started Dec 2024; status: recruiting.
02
Drugs
liocyx-m
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT06885710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06885710.